MedTrace Logo

ReVital-CORE Program

NCT04852575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2023-11-18

No results posted yet for this study

Summary

Pilot feasibility study of the ReVital Chemotherapy Online Resiliency Evaluation (CORE) program. As part of standard of care, patients starting a new chemotherapy regimen are referred to complete a pre-chemotherapy cancer rehabilitation evaluation (i.e., prehab) and invited to enroll in the ReVital-CORE program study.

Once enrolled in ReVital-CORE, participants will complete a monthly online evaluation for 1 year. If frailty (or pre-frailty) is detected on any survey, physical or occupational therapy will be initiated for standard of care rehabilitation evaluation and treatment.

Conditions

Sponsors & Collaborators

  • Select Medical

    collaborator UNKNOWN

  • Kessler Foundation

    lead OTHER

Principal Investigators

  • Mackenzi Pergolotti, PhD · Select Medical

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2023-01-25
Completion
2023-01-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04852575 on ClinicalTrials.gov